MASI (Masimo Corporation) Stock Financials & Earnings | Market Cap Arena

MASI (Masimo Corporation) Stock Financials & Earnings | Market Cap Arena

MASIMasimo Corporation

Mkt Cap$9B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Revenue (TTM)$1.5B

Net Income (TTM)-$152M

EPS (TTM)-$2.80

Free Cash Flow (TTM)$196M

Gross Margin61.9%

Op. Margin20.3%

Net Margin-9.9%

FCF Margin12.8%

P/S Ratio (TTM)6.2x

P/E Ratio (TTM)—

YoY Rev Growth-14.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$565M	$285M	$38M
Q2 23	$455M	$221M	$29M
Q3 23	$479M	$235M	$25M
Q4 23	$549M	$263M	$44M
Q1 24	$340M	$207M	$53M
Q2 24	$344M	$207M	$42M
Q3 24	$505M	$263M	$30M
Q4 24	$601M	$245M	-$359M
Q1 25	$372M	$234M	$78M
Q2 25	$371M	$233M	$65M
Q3 25	$372M	$231M	$84M
Q4 25	$413M	$247M	$84M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	4.1x	79.8x
Q2 23	4.3x	81.4x
Q3 23	4.5x	106.5x
Q4 23	4.6x	115.7x
Q1 24	5.2x	119.2x
Q2 24	5.5x	118.7x
Q3 24	5.4x	119.9x
Q4 24	5.3x	—
Q1 25	5.2x	—
Q2 25	5.1x	—
Q3 25	5.5x	—
Q4 25	6.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$400K	-$18M
Q2 23	$24M	$2M
Q3 23	-$7M	-$29M
Q4 23	$77M	$52M
Q1 24	$46M	$35M
Q2 24	$75M	$67M
Q3 24	$26M	-$5M
Q4 24	$51M	$48M
Q1 25	$31M	$27M
Q2 25	$69M	$65M
Q3 25	$57M	$51M
Q4 25	$61M	$53M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$18M
Q2 23	$22M
Q3 23	$22M
Q4 23	$25M
Q1 24	$11M
Q2 24	$7M
Q3 24	$30M
Q4 24	$3M
Q1 25	$4M
Q2 25	$5M
Q3 25	$6M
Q4 25	$7M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+85.7%	+115.5%
Q2 23	-19.5%	-21.6%
Q3 23	-12.8%	-8.3%
Q4 23	-11.0%	-7.1%
Q1 24	-39.9%	-45.6%
Q2 24	-24.5%	-29.1%
Q3 24	+5.4%	+4.6%
Q4 24	+9.4%	+90.1%
Q1 25	+9.5%	+2.6%
Q2 25	+7.9%	+1.5%
Q3 25	-26.4%	-39.3%
Q4 25	-31.3%	-65.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$7M	1.3%
Q2 23	-$9M	-1.9%
Q3 23	-$1M	-0.2%
Q4 23	$9M	1.7%
Q1 24	$9M	2.6%
Q2 24	$12M	3.5%
Q3 24	$9M	1.8%
Q4 24	$12M	2.0%
Q1 25	$9M	2.4%
Q2 25	$9M	2.3%
Q3 25	$0	0.0%
Q4 25	$9M	2.2%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$51M	$196M
Q2 23	$40M	$152M
Q3 23	$47M	$156M
Q4 23	$38M	$160M
Q1 24	$38M	$116M
Q2 24	$39M	$126M
Q3 24	$48M	$185M
Q4 24	$78M	$222M
Q1 25	$34M	$119M
Q2 25	$30M	$139M
Q3 25	$31M	$116M
Q4 25	$32M	$131M

Revenue Segments

Quarter	Health Care Segment
Q1 24	$340M
Q2 24	$344M
Q1 25	$371M
Q2 25	$370M
Q3 25	$371M
Q4 25	$412M

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$174M	$0	$174M
Q2 23	$151M	$0	$151M
Q3 23	$124M	$0	$124M
Q4 23	$163M	$0	$163M
Q1 24	$150M	$0	$150M
Q2 24	$130M	$0	$130M
Q3 24	$159M	$0	$159M
Q4 24	$178M	$0	$178M
Q1 25	$131M	$0	$131M
Q2 25	$150M	$0	$150M
Q3 25	$315M	$0	$315M
Q4 25	$152M	$0	$152M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	54M	-0.7%
Q2 23	54M	+0.0%
Q3 23	54M	-0.9%
Q4 23	54M	-0.4%
Q1 24	54M	+0.9%
Q2 24	54M	+0.2%
Q3 24	54M	+0.0%
Q4 24	54M	-1.3%
Q1 25	55M	+2.2%
Q2 25	55M	+0.0%
Q3 25	54M	-0.7%
Q4 25	54M	-0.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$187K	3K
FY 15	$525K	1K
FY 16	$574K	1K
FY 17	$564K	1K
FY 18	$572K	2K
FY 19	$586K	2K
FY 20	$715K	2K
FY 21	$620K	2K
FY 22	$509K	4K
FY 23	$539K	4K
FY 24	$582K	4K
FY 25	$436K	4K